Emerging hypervirulent Klebsiella pneumoniae: Myth, reality, and clinical relevance

Sanika Mahesh Kulkarni1,2, Jobin John Jacob1, Abi Manesh3

  • 1Department of Clinical Microbiology, Christian Medical College and Hospital, Vellore, 632004, India.

Infectious Medicine
|July 28, 2026
PubMed

Insights

Hypervirulent Klebsiella pneumoniae (hvKp) strains do not always cause higher mortality. True hypervirulence depends on specific lineages, not just virulence genes, impacting clinical risk assessment.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genomics

Background:

  • The global rise of hypervirulent Klebsiella pneumoniae (hvKp) is concerning due to invasive infections and mortality.
  • However, evidence suggests a paradox: some hvKp strains lack high mortality, while others with fewer markers are comparable to multidrug-resistant strains.
  • Traditional methods may overemphasize classical hypervirulent lineages associated with metastatic complications.

Purpose of the Study:

  • To address the definitional crisis of hvKp, where virulence gene carriage doesn't always predict clinical outcomes.
  • To propose an updated framework for K. pneumoniae pathotypes.
  • To advocate for refined laboratory diagnostics and cautious hvKp labeling.

Main Methods:

  • Systematic reviews and meta-analyses of existing data.
  • Genome-wide association studies (GWAS).
  • Phenotypic analyses focusing on virulence factors like capsular polysaccharide.
  • Synthesis of clinical, genomic, and epidemiological evidence.

Main Results:

  • Genotypically defined hvKp clones with fewer virulence markers show mortality rates similar to multidrug-resistant K. pneumoniae.
  • Capsular polysaccharide is a key virulence driver in carbapenem-resistant hvKp, independent of plasmids.
  • Only 37.3% of carbapenem-resistant hvKp with plasmid markers showed true hypervirulence.
  • Specific lineages (e.g., K1/K2 ST23 and related shadow lineages) are consistently linked to metastatic disease.

Conclusions:

  • Virulence gene carriage alone is insufficient to define hvKp or predict clinical outcomes.
  • Lineage-specific risk is crucial, exemplified by ST23 and its related lineages.
  • An updated K. pneumoniae pathotype framework integrating clonality, antimicrobial resistance (AMR), and epidemiology is needed.
  • Tiered diagnostics and careful labeling of hvKp are essential for antimicrobial stewardship and clinical decision-making.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...